A Prospective, Multicentric Study to Evaluate the Prevalence of Hypogonadism in Indian Male Patients Suffering from Type 2 Diabetes with or without Obesity

Abbott Healthcare Pvt Ltd0 个研究点目标入组 600 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1)Males from 30 years to 65 years of age with
•Known cases of type 2 diabetes mellitus > 5 years duration with or without obesity.

•1.Use of androgen therapy or anabolic steroids within 12 weeks of entry into the study.
•2.History or current diagnosis of breast or prostate cancer.
•3.Patients with known causes of hypogonadism (e.g. KlinefelterÃ¢â?¬•s syndrome,
•uncorrected cryptorchidism, surgical orchiectomy, or prior infectious orchitis)
•4.T1DM, suffering from any known chronic liver disease, renal disease, advanced malignancy,
•debilitating diseases such as tuberculosis, malabsorption, inflammatory bowel disease, pyrexia of unknown origin, acquired immunodeficiency syndrome, sickle cell disease, autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, any inflammatory disease or infection, and
•already receiving hormone replacement therapy or with severe psychological symptoms.

发起方